Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robert Berger

Surgery Flagstaff, AZ Medical Doctor

NPI 1417926874 CMS profile 18334

77 W Forest Ave Ste 201, Ste 201, Flagstaff, AZ 86001

Open in the dashboard

General payments

$9,779

88 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Robert Berger of Flagstaff, AZ is reported in the CMS Open Payments database as having received $9,779 across 88 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,408 17
2024 General $1,267 11
2023 General $486 11
2022 General $452 11
2021 General $433 7
2020 General $2,156 12
2019 General $1,577 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Berger
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Robert Berger were reported at $3,408. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Robert Berger Surgery median Middle half National median
2019 $1,577 $253 $82–$1,521 $163
2020 $2,156 $131 $40–$706 $114
2021 $433 $168 $50–$904 $132
2022 $452 $224 $76–$1,218 $149
2023 $486 $253 $82–$1,255 $160
2024 $1,267 $279 $90–$1,381 $164
2025 $3,408 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $5,425 34 payments
  2. Olympus America Inc. $1,520 7 payments
  3. Stryker Corporation $901 4 payments
  4. Covidien LP $882 10 payments
  5. TELA Bio, Inc. $279 8 payments
  6. Ethicon US, LLC $107 1 payment
  7. Davol Inc. $87 5 payments
  8. PolyMedics Innovations Inc $74 1 payment
  9. Merit Medical Systems Inc $69 1 payment
  10. Boston Scientific Corporation $62 2 payments
  11. Other $376 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $4,469 13 payments
  2. Food and Beverage $3,045 72 payments
  3. Education $2,000 2 payments
  4. Gift $265 1 payment
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $4,425 33 payments
  2. ENDOCAPSULE RECORDER $1,319 4 payments
  3. DAVINCI XI $1,000 1 payment
  4. 1788 $813 3 payments
  5. ProGrip $401 3 payments
  6. Sonicision $204 2 payments
  7. OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) $199 5 payments
  8. 4K Cable 3.0M $163 2 payments
  9. Echelon Flex $107 1 payment
  10. SurgiSleeve $94 1 payment
  11. Other $1,022 36 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

56

Median for General Surgery: 59

Drug cost

$221

Median for General Surgery: $393

Branded share of claims

100%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 56 $221

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 62 billing codes

Paid by Medicare

$68,187

Medicare's payments for the services billed

Medicare patients

168

Average age 72

Services billed

328

66 women, 102 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 61%
Arthritis 33%
Diabetes 30%
Ischemic heart disease 21%
Chronic kidney disease 21%
Depression 17%
COPD 14%
Cancer 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

88 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record